Axe Compute Inc. operates as a Nasdaq-listed neocloud AI infrastructure company delivering dedicated enterprise GPU compute capacity. Company news centers on enterprise infrastructure contracts, dedicated GPU clusters, high-speed storage for AI model training and inference, and the Strategic Compute Reserve used to convert reserve assets into deployable GPU capacity.
Recurring updates also cover financial results, capital raised to support its digital asset treasury strategy, commercial pipeline development, executive leadership changes, and investor presentations following the company's transformation from Predictive Oncology Inc. to Axe Compute.
Axe Compute (NASDAQ: AGPU) has engaged Cardiff Advisory LLC to explore strategic alternatives for its Helomics business, including potential sale, partnership, licensing, or joint venture, as the company sharpens focus on AI compute infrastructure.
The Helomics biobank includes CLIA-certified labs and approximately 150,000 live and frozen tumor samples, 40,000 FFPE tissue blocks, >b>200,000 pathology slides and digital images, and 20 years of historic drug response data across 137 tumor subtypes. The Board oversees the review and there is no assurance a transaction will result.
Axe Compute (Nasdaq: AGPU) announced on February 9, 2026 the appointment of Christopher Miglino as Chief Executive Officer to lead its decentralized GPU compute and infrastructure strategy. Mr. Miglino previously assisted in structuring the company’s digital asset treasury and entry to the AI compute market.
The board approved an inducement award: options for 500,000 shares at the closing price on the grant date, vesting one-third after one year and the remainder monthly over two years, granted outside the 2024 Equity Incentive Plan.
Axe Compute (NASDAQ: AGPU) will sponsor the Sequire Investor Summit Puerto Rico 2026, held January 20–22, 2026 at the Condado Vanderbilt Hotel in San Juan.
The summit, hosted by DNA, gathers over 500 investors and more than 75 presenting companies for presentations, panels, and networking. Axe Compute’s sponsorship signals its intent to engage institutional and retail investors and to highlight scalable, high‑performance compute and AI infrastructure opportunities.
As a sponsor, Axe Compute will participate in networking events and investor engagement throughout the three‑day conference.
Axe Compute (NASDAQ: AGPU) begins trading under ticker AGPU on December 12, 2025 and will continue its AI-driven drug discovery work while expanding into high-performance enterprise AI infrastructure.
The company plans to acquire rights to digital assets tied to compute—starting with capacity on the Aethir network—to provide guaranteed GPU capacity, SLAs, and corporate counterparty services for enterprises facing long cloud wait times.
Key context: enterprise AI cloud spending is projected to exceed $400 billion in 2025, and high-end GPU procurement timelines are cited at 40–52 weeks.